Seminars in Vascular Surgery

Seminars in Vascular Surgery is a quarterly review journal from Elsevier, issued under the W.B. Saunders imprint, that devotes each issue to a single clinical problem in vascular and endovascular practice. It began in 1988, its editor-in-chief works at the Johns Hopkins University School of Medicine, and it publishes commissioned thematic collections rather than primary research. Its 2025 Journal Impact Factor is 2.4 and its CiteScore is 4.6.《Seminars in Vascular Surgery》是 Elsevier 以 W.B. Saunders 品牌出版的季度综述期刊，每期只讨论血管外科与腔内治疗中的一个临床问题。该刊 1988 年创刊，主编任职于约翰斯·霍普金斯大学医学院，刊登约稿性质的专题合集而不发表原始研究。2025 年期刊影响因子为 2.4，CiteScore 为 4.6。

Scope

• The stated aim is narrow by design. Each issue examines the latest thinking on one clinical problem and sets out the diagnostic and operative techniques now used to manage it, so that practising surgeons can extend their range.该刊宗旨刻意收得很窄。每期审视一个临床问题的最新认识，交代当前处理该问题所用的诊断与手术技术，让执业外科医生借此拓展操作范围。
• Aortic disease dominates the catalogue. Ascending and arch repair, thoracoabdominal aneurysm, type B dissection and the device platforms built for each aortic segment have all carried entire issues in recent volumes.主动脉病变在篇目中占比最高。升主动脉与主动脉弓修复、胸腹主动脉瘤、B 型夹层，以及为主动脉各节段设计的器械平台，近年都曾独占整期。
• Carotid work runs through the file. Trial evidence on endarterectomy against stenting, the measurement of procedural stroke risk and the selection of asymptomatic patients are recurring subjects, and a 2026 collection revisited contemporary management of carotid artery stenosis.颈动脉相关内容贯穿刊史。内膜剥脱与支架置入的试验证据、围手术期卒中风险的测量、无症状患者的选择，都是反复出现的题目，2026 年一期合集重新梳理了颈动脉狭窄的当代处理。
• Peripheral arterial disease and chronic limb-threatening ischemia appear as reviews of bypass grafting, plain and drug-coated balloon angioplasty, atherectomy and the organisation of limb-salvage services.外周动脉疾病与慢性肢体威胁性缺血以综述形式呈现，涉及旁路移植、普通球囊与药物涂层球囊成形、斑块旋切，以及保肢服务的组织方式。
• Venous topics take in varicose veins, chronic venous insufficiency, iliofemoral deep vein thrombosis and post-thrombotic syndrome. Reviews on lymphedema and lymphatic surgery are fewer, yet they keep appearing.静脉方向涵盖下肢静脉曲张、慢性静脉功能不全、髂股深静脉血栓与血栓后综合征。淋巴水肿与淋巴外科的综述数量偏少，但一直稳定出现。
• Hemodialysis access has a standing place in the schedule. Fistula planning and maturation, graft surveillance, catheter-related infection and the rescue of failing accesses all turn up as review subjects.血液透析通路在选题中长期占位。内瘘的规划与成熟、移植物监测、导管相关感染，以及失功通路的挽救，都曾作为综述题目出现。
• Vascular trauma and emergency vascular surgery have received dedicated issues, covering extremity injury, resuscitative endovascular balloon occlusion and damage-control approaches in the operating room.血管创伤与急诊血管外科得到过专期，内容覆盖肢体血管损伤、复苏性主动脉腔内球囊阻断，以及手术室内的损伤控制策略。
• Noninvasive diagnosis belongs to the remit. Duplex ultrasound, computed tomographic angiography and magnetic resonance angiography are reviewed with attention to the point at which each modality changes a surgical decision.无创诊断属于刊物范围。双功超声、计算机断层血管成像与磁共振血管成像都设有综述，重点在于每种检查在哪个节点上会改变手术决策。
• Device-centred reviews describe stent grafts, balloons, covered metal stents and access-site closure systems, and set registry and trial evidence on durability beside what high-volume operators report from practice.以器械为中心的综述介绍覆膜支架、球囊、覆膜金属支架与穿刺点闭合系统，并把注册数据与试验数据中的耐久性结论同高流量术者的经验并列对照。
• Open operative craft has not been retired from the pages. Exposure, conduit choice, graft infection and the reoperative abdomen and groin are each treated in their own right.开放手术的基本功并未从版面退出。显露途径、移植物材料选择、人工血管感染，以及再次手术的腹部与腹股沟，都有独立成篇的讨论。
• Medical management runs alongside the technical material, with reviews on anticoagulation, antiplatelet strategy, risk stratification and the perioperative care of patients carrying several comorbidities.药物治疗与技术内容并行，抗凝方案、抗血小板策略、风险分层，以及合并多种基础疾病患者的围手术期管理，都在综述范围之内。
• Quality and outcomes work draws on registries, administrative claims and single-centre series to examine case selection, volume-outcome gradients and the way complications are defined and counted.质量与结局研究依托注册数据库、行政理赔数据与单中心病例系列，考察病例选择、手术量与结局之间的梯度，以及并发症的定义与统计口径。
• Team-based practice is addressed head-on. A 2025 collection on complex vascular disorders gathered contributions on shared decision-making, the roles of allied health staff and the running of multidisciplinary clinics.团队协作被正面讨论。2025 年一期关于复杂血管疾病的合集收录了共同决策、相关健康专业人员分工与多学科门诊运作方面的文章。
• Care of older and frail patients has its own issue, covering frailty assessment, conversations about goals of care and the boundary beyond which further intervention stops serving the patient.老年与衰弱患者的照护单独成期，涉及衰弱评估、治疗目标的沟通，以及继续干预不再有益于患者的那条界限。
• Training, simulation, credentialing and payment policy complete the scope, a mix that shows how far the editors read the remit of a vascular journal.培训、模拟训练、资质认证与支付政策补足了范围，编辑部把这些内容一并视为血管外科刊物的职责。

History

• The first volume appeared in 1988 from W.B. Saunders of Philadelphia, in the years when vascular surgery was separating from general surgery as a specialty of its own.首卷由费城的 W.B. Saunders 于 1988 年推出。那几年血管外科正从普通外科中独立出来，自成一门专科。
• Volume 6 opened in 1993, the year the National Library of Medicine took the title into MEDLINE and PubMed. Coverage has run from volume 6, number 1 without a break.第 6 卷始于 1993 年，美国国立医学图书馆同年将该刊收入 MEDLINE 与 PubMed，收录自第 6 卷第 1 期起延续至今，未曾中断。
• The single-topic model was fixed from the start. A guest editor takes one operation, one disease or one controversy, recruits the authors and writes the opening editorial that frames the collection.每期一题的模式自创刊起就已确定。客座主编围绕一台手术、一种疾病或一场争议组稿，约请作者并撰写开篇社论，为整期合集定下框架。
• Saunders itself changed hands more than once. The imprint sat inside Harcourt Brace Jovanovich at launch and reached Elsevier in 2001, when Reed Elsevier bought Harcourt's scientific and medical publishing business.Saunders 本身几经易主。创刊时该品牌隶属于 Harcourt Brace Jovanovich，2001 年 Reed Elsevier 收购 Harcourt 的科学与医学出版业务，刊物随之进入 Elsevier。
• The Saunders name survived the transfer. Elsevier still lists the journal under the Elsevier - WB Saunders imprint, and the Philadelphia place of publication recorded by NLM has outlived the dispersal of the original editorial office.Saunders 的名号在转手后保留下来。Elsevier 至今以 Elsevier - WB Saunders 品牌标注该刊，美国国立医学图书馆著录的费城出版地也一直沿用，最初的编辑部早已分散到各处。
• Volume numbering has run unbroken since 1988, and the four issues of a volume still appear in March, June, September and December, a quarterly rhythm the journal has never abandoned.卷号自 1988 年起连续编排，每卷四期仍在 3 月、6 月、9 月与 12 月出版，这套季度节奏从未改变。
• Print ISSN 0895-7967 dates from the first volume. The electronic ISSN 1558-4518 was added for the online edition, which now carries current issues and the complete back file on ScienceDirect.印刷版 ISSN 0895-7967 自首卷沿用至今。电子版 ISSN 1558-4518 随网络版增设，现行各期与全部过刊现在由 ScienceDirect 承载。
• Digital delivery changed how the material is used. Reviews appear as individually citable articles with their own DOIs, so the themed issue survives as an organising idea rather than as the unit of access.数字化改变了这批内容的使用方式。综述以可独立引用的文章发布，各自带有 DOI，专题期号更接近一种组织思路，而非访问与计量的单位。
• Recent volumes show the formula intact. Vascular Care in the Aging Population ran in September 2025 under Sonia Talathi and Yana Etkin, and a carotid collection edited by Jesse A. Columbo followed in March 2026.近几卷仍沿用同一套路。《Vascular Care in the Aging Population》于 2025 年 9 月出版，由（Sonia Talathi）与（Yana Etkin）主编，随后（Jesse A. Columbo）主编的颈动脉合集在 2026 年 3 月推出。
• Citation metrics have moved sharply. The Journal Impact Factor stood at 1.222 for 2022, climbed to 3.3 for 2023 and has held at 2.4 for both 2024 and 2025.影响因子起伏明显。2022 年为 1.222，2023 年升至 3.3，2024 年与 2025 年均为 2.4。
• In the 2025 Journal Citation Reports the title sits Q3 in PERIPHERAL VASCULAR DISEASE, at 53 of 100, and Q2 in SURGERY, at 95 of 321. The gap shows how differently the two audiences cite review literature.在 2025 年期刊引证报告中，该刊在 PERIPHERAL VASCULAR DISEASE 类目位列 Q3，排名 53/100，在 SURGERY 类目位列 Q2，排名 95/321，两个类目的落差反映出两类读者引用综述的习惯差异。
• Output stays small by intent. JCR counted nine citable items in 2025, and citations have accumulated slowly, reaching about 1,300 in total with a cited half-life close to five years.发文量有意保持小规模。期刊引证报告 2025 年统计的可引用文献为 9 篇，累计被引约 1300 次，被引半衰期接近五年。
• Open access arrived as an option rather than a conversion. The journal runs hybrid publication, roughly 22 percent of 2025 content was gold open access, and subscription articles stay closed to non-subscribers.开放获取以选项形式引入，订阅制主体并未改变。该刊实行混合出版，2025 年约 22% 的内容为金色开放获取，其余文章仍只对订阅者开放。

Editors

• Caitlin W. Hicks, a vascular surgeon at the Johns Hopkins University School of Medicine in Baltimore, holds the editor-in-chief post. Her published work centres on vascular outcomes and health services research.主编为（Caitlin W. Hicks），在巴尔的摩的约翰斯·霍普金斯大学医学院从事血管外科，其发表成果以血管疾病结局与卫生服务研究为主。
• The board is compact. Elsevier lists 21 editors and board members from three countries, eighteen in the United States, two in Canada and one in France, which keeps the journal North American in outlook.编委会规模不大。Elsevier 列出 21 位编辑与编委，来自三个国家，其中美国 18 位、加拿大 2 位、法国 1 位，整体取向偏北美。
• Several members carry defined portfolios. Anahita Dua at Massachusetts General Hospital works on carotid, peripheral and aortic disease, and Peter Rossi at the Medical College of Wisconsin on aortic dissection and visceral aneurysm.多位编委带有明确的方向标注。（Anahita Dua）在麻省总医院主攻颈动脉、外周与主动脉疾病，（Peter Rossi）在威斯康星医学院专注主动脉夹层与内脏动脉瘤。
• One European member, Fabien Lareyre of the Antibes Juan les Pins Hospital Center, works on artificial intelligence and e-health in vascular surgery. His presence marks how far the journal's net now reaches beyond open technique.唯一来自欧洲的编委（Fabien Lareyre）在法国昂蒂布执业，研究方向为血管外科中的人工智能与电子健康。他的加入也说明刊物视野已超出单纯的手术技巧。
• Guest editors are named issue by issue and are usually senior specialists in the subject. Sara L. Zettervall led the 2026 collection on endovascular management of the aortic arch, Eric A. Secemsky the 2025 issue on team-based care.客座主编逐期指定，多为该领域的资深专家。（Sara L. Zettervall）主持了 2026 年主动脉弓腔内治疗合集，（Eric A. Secemsky）主持了 2025 年团队协作专题。
• Almost everything is commissioned. Proposals for a themed issue go to the editor-in-chief, who weighs whether the topic is timely and whether a guest editor with the standing to recruit the right authors can be found.绝大多数稿件来自约稿。专题设想提交主编，由主编判断选题是否合时，以及能否找到有号召力、可以约到合适作者的客座主编。
• Peer review is single anonymized. Reviewers know the authors, authors do not know the reviewers, and submissions judged suitable go to at least two external referees.评审采用单盲形式。评审人知晓作者身份，作者不知评审人是谁，通过初筛的稿件至少送两位外审。
• Themed collections follow the same standard with one difference. A guest editor may send manuscripts out and recommend a decision, while the editor-in-chief keeps the final call and oversight of publishing ethics.专题合集遵循同一标准，差别在于客座主编可以送出稿件并给出处理建议，最终决定权与学术伦理监督仍归主编。
• Turnaround is advertised on the journal page. Five days pass from submission to a first decision, 30 days to a decision after review, 61 days to acceptance and five days from acceptance to online publication.处理速度在刊页上公开。投稿到首次决定需 5 天，送审后到决定需 30 天，投稿到录用需 61 天，录用到线上发表需 5 天。
• Decisions can be appealed once under Elsevier's appeal policy. Editors also step aside from any manuscript they wrote, co-authored or hold a commercial interest in.作者可依 Elsevier 的申诉政策提出一次申诉。编辑若撰写、参与撰写相关稿件，或与之存在商业利益，则回避该稿的处理。
• Each collection opens with a short editorial, usually by the guest editor, that states why the topic matters now and what the assembled reviews are meant to settle.每期合集以一篇短社论开篇，多由客座主编执笔，说明该选题为何在此刻重要，以及这组综述希望解决什么问题。
• Authors come from well beyond the board, and the reviews set North American practice beside European and Asian experience. Topics such as device availability and access to aortic centres need that contrast.作者来源远超出编委会，综述把北美做法与欧洲、亚洲的经验并置。器械可及性与主动脉中心转诊条件这类题目尤其需要这种对照。
• The masthead carries no deputy or associate editors between the editor-in-chief and the board, so the thematic work is carried issue by issue by named guest editors.刊头在主编与编委之间不设副主编或助理编辑，专题工作便由逐期署名的客座主编承担。